Skip to main content
Top
Published in: Digestive Diseases and Sciences 9/2008

01-09-2008 | Original Article

Persistence of Hepatitis C Virus in Peripheral Blood Mononuclear Cells of Sustained Viral Responders to Pegylated Interferon and Ribavirin Therapy

Authors: Juan F. Gallegos-Orozco, Jorge Rakela, Marianne J. Rosati, Hugo E. Vargas, Vijayan Balan

Published in: Digestive Diseases and Sciences | Issue 9/2008

Login to get access

Abstract

The aim of this paper was to assess the persistence of hepatitis C virus (HCV) among patients successfully treated with peginterferon and ribavirin. The persistence of viral RNA was evaluated in the serum and peripheral blood mononuclear cells (PBMCs) of 25 chronic hepatitis C patients with sustained viral response to peginterferon and ribavirin treatment up to 56 months after the completion of therapy. Viral RNA was detected in the peripheral blood mononuclear cell cultures of five patients (20%), but none had detectable serum HCV RNA. At present, the clinical relevance of this finding is unclear. It is possible that viral persistence and, specifically, the presence of HCV RNA in PBMCs may lead to HCV reactivation under special circumstances, such as immunosuppression.
Literature
2.
go back to reference Yan FM, Chen AS, Hao F, Zhao XP, Gu CH, Zhao LB et al (2000) Hepatitis C virus may infect extrahepatic tissues in patients with hepatitis C. World J Gastroenterol 6(6):805–811PubMed Yan FM, Chen AS, Hao F, Zhao XP, Gu CH, Zhao LB et al (2000) Hepatitis C virus may infect extrahepatic tissues in patients with hepatitis C. World J Gastroenterol 6(6):805–811PubMed
3.
go back to reference Vargas HE, Laskus T, Radkowski M, Wilkinson J, Balan V, Douglas DD et al (2002) Detection of hepatitis C virus sequences in brain tissue obtained in recurrent hepatitis C after liver transplantation. Liver Transpl 8(11):1014–1019. doi:10.1053/jlts.2002.36393 PubMedCrossRef Vargas HE, Laskus T, Radkowski M, Wilkinson J, Balan V, Douglas DD et al (2002) Detection of hepatitis C virus sequences in brain tissue obtained in recurrent hepatitis C after liver transplantation. Liver Transpl 8(11):1014–1019. doi:10.​1053/​jlts.​2002.​36393 PubMedCrossRef
4.
go back to reference Sugiyama K, Kato N, Ikeda M, Mizutani T, Shimotohno K, Kato T et al (1997) Hepatitis C virus in pelvic lymph nodes and female reproductive organs. Jpn J Cancer Res 88(10):925–927PubMed Sugiyama K, Kato N, Ikeda M, Mizutani T, Shimotohno K, Kato T et al (1997) Hepatitis C virus in pelvic lymph nodes and female reproductive organs. Jpn J Cancer Res 88(10):925–927PubMed
6.
go back to reference Willems M, Peerlinck K, Moshage H, Deleu I, Van den Eynde C, Vermylen J et al (1994) Hepatitis C virus-RNAs in plasma and in peripheral blood mononuclear cells of hemophiliacs with chronic hepatitis C: evidence for viral replication in peripheral blood mononuclear cells. J Med Virol 42(3):272–278. doi:10.1002/jmv.1890420314 PubMedCrossRef Willems M, Peerlinck K, Moshage H, Deleu I, Van den Eynde C, Vermylen J et al (1994) Hepatitis C virus-RNAs in plasma and in peripheral blood mononuclear cells of hemophiliacs with chronic hepatitis C: evidence for viral replication in peripheral blood mononuclear cells. J Med Virol 42(3):272–278. doi:10.​1002/​jmv.​1890420314 PubMedCrossRef
7.
go back to reference Okuda M, Hino K, Korenaga M, Yamaguchi Y, Katoh Y, Okita K (1999) Differences in hypervariable region 1 quasispecies of hepatitis C virus in human serum, peripheral blood mononuclear cells, and liver. Hepatology 29(1):217–222. doi:10.1002/hep.510290117 PubMedCrossRef Okuda M, Hino K, Korenaga M, Yamaguchi Y, Katoh Y, Okita K (1999) Differences in hypervariable region 1 quasispecies of hepatitis C virus in human serum, peripheral blood mononuclear cells, and liver. Hepatology 29(1):217–222. doi:10.​1002/​hep.​510290117 PubMedCrossRef
8.
go back to reference Castillo I, Rodríguez-Iñigo E, Bartolome J, de Lucas S, Ortíz-Movilla N, López-Alcorocho JM et al (2005) Hepatitis C virus replicates in peripheral blood mononuclear cells of patients with occult hepatitis C virus infection. Gut 54(5):682–685. doi:10.1136/gut.2004.057281 PubMedCrossRef Castillo I, Rodríguez-Iñigo E, Bartolome J, de Lucas S, Ortíz-Movilla N, López-Alcorocho JM et al (2005) Hepatitis C virus replicates in peripheral blood mononuclear cells of patients with occult hepatitis C virus infection. Gut 54(5):682–685. doi:10.​1136/​gut.​2004.​057281 PubMedCrossRef
9.
go back to reference Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R et al (2001) Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358(9286):958–965. doi:10.1016/S0140-6736(01)06102-5 PubMedCrossRef Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R et al (2001) Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358(9286):958–965. doi:10.​1016/​S0140-6736(01)06102-5 PubMedCrossRef
10.
go back to reference Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Gonçales FL Jr et al (2002) Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347(13):975–982. doi:10.1056/NEJMoa020047 PubMedCrossRef Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Gonçales FL Jr et al (2002) Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347(13):975–982. doi:10.​1056/​NEJMoa020047 PubMedCrossRef
11.
go back to reference Hadziyannis SJ, Sette H Jr, Morgan TR, Balan V, Diago M, Marcellin P et al (2004) Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med 140(5):346–355PubMed Hadziyannis SJ, Sette H Jr, Morgan TR, Balan V, Diago M, Marcellin P et al (2004) Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med 140(5):346–355PubMed
13.
go back to reference Marcellin P, Boyer N, Gervais A, Martinot M, Pouteau M, Castelnau C et al (1997) Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy. Ann Intern Med 127(10):875–881PubMed Marcellin P, Boyer N, Gervais A, Martinot M, Pouteau M, Castelnau C et al (1997) Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy. Ann Intern Med 127(10):875–881PubMed
14.
go back to reference Poynard T, McHutchison J, Manns M, Trepo C, Lindsay K, Goodman Z et al (2002) Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology 122(5):1303–1313. doi:10.1053/gast.2002.33023 PubMedCrossRef Poynard T, McHutchison J, Manns M, Trepo C, Lindsay K, Goodman Z et al (2002) Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology 122(5):1303–1313. doi:10.​1053/​gast.​2002.​33023 PubMedCrossRef
15.
go back to reference Tanaka H, Tsukuma H, Kasahara A, Hayashi N, Yoshihara H, Masuzawa M et al (2000) Effect of interferon therapy on the incidence of hepatocellular carcinoma and mortality of patients with chronic hepatitis C: a retrospective cohort study of 738 patients. Int J Cancer 87(5):741–749. doi:10.1002/1097-0215(20000901)87:5<741::AID-IJC18>3.0.CO;2-BPubMedCrossRef Tanaka H, Tsukuma H, Kasahara A, Hayashi N, Yoshihara H, Masuzawa M et al (2000) Effect of interferon therapy on the incidence of hepatocellular carcinoma and mortality of patients with chronic hepatitis C: a retrospective cohort study of 738 patients. Int J Cancer 87(5):741–749. doi:10.1002/1097-0215(20000901)87:5<741::AID-IJC18>3.0.CO;2-BPubMedCrossRef
18.
go back to reference Radkowski M, Gallegos-Orozco JF, Jablonska J, Colby TV, Walewska-Zielecka B, Kubicka J et al (2005) Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Hepatology 41(1):106–114. doi:10.1002/hep.20518 PubMedCrossRef Radkowski M, Gallegos-Orozco JF, Jablonska J, Colby TV, Walewska-Zielecka B, Kubicka J et al (2005) Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Hepatology 41(1):106–114. doi:10.​1002/​hep.​20518 PubMedCrossRef
19.
20.
go back to reference Laskus T, Radkowski M, Wang LF, Nowicki M, Rakela J (2000) Uneven distribution of hepatitis C virus quasispecies in tissues from subjects with end-stage liver disease: confounding effect of viral adsorption and mounting evidence for the presence of low-level extrahepatic replication. J Virol 74(2):1014–1017. doi:10.1128/JVI.74.2.1014-1017.2000 PubMedCrossRef Laskus T, Radkowski M, Wang LF, Nowicki M, Rakela J (2000) Uneven distribution of hepatitis C virus quasispecies in tissues from subjects with end-stage liver disease: confounding effect of viral adsorption and mounting evidence for the presence of low-level extrahepatic replication. J Virol 74(2):1014–1017. doi:10.​1128/​JVI.​74.​2.​1014-1017.​2000 PubMedCrossRef
21.
go back to reference Laskus T, Radkowski M, Jablonska J, Kibler K, Wilkinson J, Adair D et al (2004) Human immunodeficiency virus facilitates infection/replication of hepatitis C virus in native human macrophages. Blood 103(10):3854–3859. doi:10.1182/blood-2003-08-2923 PubMedCrossRef Laskus T, Radkowski M, Jablonska J, Kibler K, Wilkinson J, Adair D et al (2004) Human immunodeficiency virus facilitates infection/replication of hepatitis C virus in native human macrophages. Blood 103(10):3854–3859. doi:10.​1182/​blood-2003-08-2923 PubMedCrossRef
22.
23.
go back to reference Lee WM, Polson JE, Carney DS, Sahin B, Gale M Jr (2005) Reemergence of hepatitis C virus after 8.5 years in a patient with hypogammaglobulinemia: evidence for an occult viral reservoir. J Infect Dis 192(6):1088–1092. doi:10.1086/432917 PubMedCrossRef Lee WM, Polson JE, Carney DS, Sahin B, Gale M Jr (2005) Reemergence of hepatitis C virus after 8.5 years in a patient with hypogammaglobulinemia: evidence for an occult viral reservoir. J Infect Dis 192(6):1088–1092. doi:10.​1086/​432917 PubMedCrossRef
Metadata
Title
Persistence of Hepatitis C Virus in Peripheral Blood Mononuclear Cells of Sustained Viral Responders to Pegylated Interferon and Ribavirin Therapy
Authors
Juan F. Gallegos-Orozco
Jorge Rakela
Marianne J. Rosati
Hugo E. Vargas
Vijayan Balan
Publication date
01-09-2008
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 9/2008
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-008-0323-x

Other articles of this Issue 9/2008

Digestive Diseases and Sciences 9/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.